Medical Weight Loss for Frisco, Texas Residents
Frisco, Texas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Frisco through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Frisco Residents Choose New Hope Weight Loss
Frisco patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Texas and beyond since 2020.
Frisco is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Frisco patients at home.
For Frisco, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout Downtown, the Star district, and the greater Collin County area. There is no distance surcharge for Frisco patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Whether you live in central Frisco or its outskirts, you get exactly the same care and the same price. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Frisco patients.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Frisco patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Frisco
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Frisco address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Frisco
How do I get treatment from Frisco?
As a Frisco, Texas patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Frisco?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Frisco in cold-pack packaging, no lines and no drive.
How much does it cost for Frisco patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Frisco do you serve?
We serve patients from across Frisco by telehealth, including Downtown, the Star district, and the greater Collin County area.
How soon can a Frisco patient start treatment?
Most Frisco patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Frisco, Texas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.